However, CPAP therapy did not improve the abnormal expression of DRD5 and TFAP2A in adipose tissue among OSA patients in the GSE135917 dataset (Supplementary Table S1). This evidence concerns the gene TFAP2A and obstructive sleep apnea syndrome.